Agilent Technologies
  • A

  • $114.96

  • +0.15%
  • $114.79

  • $116.36

  • $113.68

Prices as of 2026-05-22 16:20:48 ET

Ticker Appearances

Daily Technical Strategy
Wed, January 7, 2026 | 9:51PM ET

Healthcare being raised to Overweight after breakout

NEAR-TERM EQUITY TRENDS ARE BULLISH, AND IT’S EXPECTED THAT QQQ WILL SOON BREAK OUT TO JOIN THE MOVE BACK TO NEW HIGHS, WHICH HAS BEEN...

This report is accessible to Fundstrat Pro & Fundstrat Macro memberships. Sign up Here!

You currently can unlock 2 Macro reports this month.

Current usage: Macro (0/2)

Already have an account? Sign In

Visitor: unknown

Daily Technical Strategy
Mon, November 24, 2025 | 7:07PM ET
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships. Sign up Here!

You currently can unlock 2 Macro reports this month.

Current usage: Macro (0/2)

Already have an account? Sign In

Visitor: unknown

Daily Technical Strategy
Tue, January 21, 2025 | 7:43PM ET
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships. Sign up Here!

You currently can unlock 2 Macro reports this month.

Current usage: Macro (0/2)

Already have an account? Sign In

Visitor: unknown

Daily Technical Strategy
Tue, May 28, 2024 | 8:12PM ET
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships. Sign up Here!

You currently can unlock 2 Macro reports this month.

Current usage: Macro (0/2)

Already have an account? Sign In

Visitor: unknown

Daily Technical Strategy
Tue, November 21, 2023 | 8:13PM ET
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships. Sign up Here!

You currently can unlock 2 Macro reports this month.

Current usage: Macro (0/2)

Already have an account? Sign In

Visitor: unknown

Technical Strategy
Wed, November 24, 2021 | 5:51PM ET
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships. Sign up Here!

You currently can unlock 2 Macro reports this month.

Current usage: Macro (0/2)

Already have an account? Sign In

Visitor: unknown

Events

Trending tickers in our research